ciprokiren has been researched along with Acute-Disease* in 1 studies
1 other study(ies) available for ciprokiren and Acute-Disease
Article | Year |
---|---|
Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure.
To determine the role of the renin-angiotensin system in a model of acute heart failure.. Placebo or drugs (Ro 44-9375, a renin inhibitor; captopril, an angiotensin-converting enzyme [ACE] inhibitor; or DuP 532, an angiotensin II receptor [AT1] antagonist) were given to anesthetized splenectomized dogs (n = 12 for each group) for 50 mins after a volume load (dextran 70, 25 mL/kg over 10 mins) during rapid right ventricular pacing at 250 beats/min. Total vascular compliance and capacitance were determined from mean circulatory filling pressure-blood volume curves during transient circulatory arrests induced by acetylcholine. Cardiac index was measured by thermal dilution.. Compared with the untreated group, all three drugs significantly reduced systemic pressure and total peripheral resistance while increasing arterial compliance. Captopril alone increased cardiac index (25 +/- 11 versus -23 +/- 13 mL/kg/min) and reduced pulmonary capillary wedge pressure (16.6 +/- 0.7 versus 21.9 +/- 1.0 mmHg). None of the drugs altered the mean circulatory filling pressure, total vascular compliance or capacitance, stressed or unstressed blood volumes, or central blood volume.. The renin-angiotensin system is not strongly implicated in the hemodynamic manifestations of this model of acute heart failure. These drugs had effects on the arterial but not the venous side of the circulation. Captopril alone reduced pulmonary capillary wedge pressure, perhaps by nonangiotensin effects. Topics: Acute Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Volume; Captopril; Cardiac Output, Low; Cardiac Pacing, Artificial; Dogs; Dose-Response Relationship, Drug; Female; Imidazoles; Male; Renin-Angiotensin System; Stroke Volume; Tetrazoles; Vascular Resistance; Ventricular Function, Left | 1995 |